Cargando…
Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands
Vaccine efficacy is optimized by addition of immune adjuvants. However, although adjuvants have been used for over a century, to date, only few adjuvants are approved for human use, mostly aimed at improving vaccine efficacy and antigen-specific protective antibody production. The mechanism of actio...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494261/ https://www.ncbi.nlm.nih.gov/pubmed/26344622 http://dx.doi.org/10.3390/vaccines2020323 |